Inhibitors of immune complex induced human platelet aggregation and release in plasma.
D000906:Antibodies / Q000276:immunology*; D000936:Antigen-Antibody Complex / Q000276:immunology*; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000276:immunology*; D004247:DNA / Q000276:immunology*; D003864:Depression, Chemical; D004176:Dipyridamole / Q000494:pharmacology; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D008180:Lupus Erythematosus, Systemic / Q000097:blood; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects*; D011799:Quinazolines / Q000494:pharmacology; D011961:Receptors, Fc / Q000276:immunology*; D013442:Sulfinpyrazone / Q000494:pharmacology
D000906:Antibodies; D000936:Antigen-Antibody Complex; D007093:Imidazoles; D011799:Quinazolines; D011961:Receptors, Fc; D004176:Dipyridamole; D004247:DNA; C021139:anagrelide; C018100:1-methylimidazole; D001241:Aspirin; D013442:Sulfinpyrazone; D007213:Indomethacin